The stock has a 36-month beta value of 0.20. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 0 as “overweight,” 18 as “hold,” and 0 as “sell.”
The public float for AGL is 301.50M, and at present, short sellers hold a 6.06% of that float. On April 21, 2025, the average trading volume of AGL was 5.83M shares.
AGL) stock’s latest price update
The stock of Agilon Health Inc (NYSE: AGL) has decreased by -26.87 when compared to last closing price of 5.47. Despite this, the company has experienced a -27.27% fall in its stock price over the last five trading sessions. seekingalpha.com reported 2025-04-10 that agilon health’s stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon’s business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners.
AGL’s Market Performance
Agilon Health Inc (AGL) has seen a -27.27% fall in stock performance for the week, with a -9.09% decline in the past month and a 35.14% surge in the past quarter. The volatility ratio for the week is 14.45%, and the volatility levels for the past 30 days are at 9.88% for AGL. The simple moving average for the last 20 days is -15.17% for AGL stock, with a simple moving average of 6.52% for the last 200 days.
Analysts’ Opinion of AGL
Many brokerage firms have already submitted their reports for AGL stocks, with Bernstein repeating the rating for AGL by listing it as a “Outperform.” The predicted price for AGL in the upcoming period, according to Bernstein is $8.50 based on the research report published on April 08, 2025 of the current year 2025.
Citigroup, on the other hand, stated in their research note that they expect to see AGL reach a price target of $2.25, previously predicting the price at $1.75. The rating they have provided for AGL stocks is “Neutral” according to the report published on January 10th, 2025.
AGL Trading at -1.24% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.25% of loss for the given period.
Volatility was left at 9.88%, however, over the last 30 days, the volatility rate increased by 14.45%, as shares sank -2.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.29% upper at present.
During the last 5 trading sessions, AGL fell by -27.27%, which changed the moving average for the period of 200-days by -34.10% in comparison to the 20-day moving average, which settled at $4.72. In addition, Agilon Health Inc saw 110.53% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from McLoughlin Karen, who purchase 25,000 shares at the price of $2.20 back on Dec 13 ’24. After this action, McLoughlin Karen now owns 73,166 shares of Agilon Health Inc, valued at $55,085 using the latest closing price.
Battaglia Silvana, the Director of Agilon Health Inc, purchase 25,062 shares at $2.01 during a trade that took place back on Dec 11 ’24, which means that Battaglia Silvana is holding 66,144 shares at $50,269 based on the most recent closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- -0.0 for the gross margin
The net margin for Agilon Health Inc stands at -0.04. The total capital return value is set at -0.5. Equity return is now at value -44.20, with -14.41 for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -1.39. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -46.76.
Currently, EBITDA for the company is -218.19 million with net debt to EBITDA at 0.64. When we switch over and look at the enterprise to sales, we see a ratio of 0.25. The receivables turnover for the company is 5.96for trailing twelve months and the total asset turnover is 3.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
To sum up, Agilon Health Inc (AGL) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
